You have read all your free articles, to continue reading subscribe to read the rest of this content.
Danish biotechnology company Ascendis Pharma has appointed Martin Auster, M.D., as Chief Business Officer. Dr. Auster joins the company from United Therapeutics, where he has served as Vice President, Business Development. Prior to United Therapeutics, Dr. Auster held positions in the investmenAlready a subscriber Login You have read all your free articles,…
Idogen has announces that Anders Karlsson has decided to leave the company to move on to a CEO role in another Swedish biotechnology company. "It has been a privilege to lead Idogen for the past three years and I am convinced that the company's competent board and employees will continue…
The company appoints Michael Engsig, a pharmaceutical professional with more than two decades of experience and a successful track record in R&D and commercial functions, as Chief Operating Officer. Before joining Vaccibody, Michael was EVP Drug Development Counselling and Business DevelopmenAlready a subscriber Login You have read all your free…
Professor Anders Fasth steps in as an advisor in the development of medicines for inflammatory diseases. Lipum has developed a biological drug candidate for the treatment of chronic inflammatory diseases and aim for a better treatment of juvenile idiopathic arthritis (JIA), that affects children.Already a subscriber Login You have read…
